Johnson & Johnson (JNJ)
FSX
Closed
Oct 7, 2026
Day's Range
227.0052 wk Range
156.98Overview - JNJ - Johnson & Johnson
Key Statistics
Valuation
Enterprise Value
528.71B
P/E (Trailing)
‪31.44‬
PEG Ratio
‪-275.06‬
Price / Sales (TTM)
‪5.86‬
Price / Book
‪7.75‬
EV / EBITDA
‪17.28‬
Profitability
Gross Margin
‪68.19%‬
Profit Margin
‪21.48%‬
Operating Margin
‪29.19%‬
Return on Assets
‪8.59%‬
Return on Equity
‪25.74%‬
Ownership
Shares Outstanding
2.40B
Float
2.40B
Held by Insiders
‪0.05%‬
Held by Institutions
‪76.72%‬
Price stats
Beta
‪0.23‬
50-Day Avg
‪229.72‬
200-Day Avg
‪207.58‬
Dividends
Payout Ratio
‪60.79%‬
Frequency
Quarterly
Market Cap - JNJ - Johnson & Johnson
Peers - JNJ - Johnson & Johnson
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on FSX.
Profile Summary - JNJ - Johnson & Johnson
About
Johnson & Johnson is a multinational healthcare company focused on Innovative Medicine and MedTech. Johnson & Johnson develops prescription medicines across areas such as immunology, oncology, neuroscience, cardiopulmonary disease, infectious disease, and metabolic disorders, while its MedTech business provides…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
